Featured Article
The Connection Between Cardiovascular Disease and Sleep Apnea: An Expert Interview
To examine the link between cardiovascular disease and sleep apnea, The Cardiology Advisor spoke with cardiologist Seth S. Martin, MD, MHS, FACC, FAHA and sleep specialist Rachel Marie E. Salas, MD, FAAN.
Latest Features
The Connection Between Cardiovascular Disease and Sleep Apnea: An Expert Interview
To examine the link between cardiovascular disease and sleep apnea, The Cardiology Advisor spoke with cardiologist Seth S. Martin, MD, MHS, FACC, FAHA and sleep specialist Rachel Marie E. Salas, MD, FAAN.
Managing Heart Failure: Improving Quality of Life and Preventing Excerbations
Heart failure is the number 1 reason for patient re-admittance to acute-care facilities according to the American Heart Association.
Preventing Heart Failure One Risk Factor at a Time
Avoiding 3 major risk factors for heart failure—hypertension, diabetes, and obesity—may reduce the likelihood of heart failure development.
Hope for Heart Failure in Thyroid Hormone Therapy
Subclinicial hypothyroidism has been associated with an increased risk for coronary heart disease events and mortality.
Premature Ventricle Contractions in Heart Failure: A Closer Examination
A primer on premature ventricle contractions with commentary from 2 arrhythmic/heart failure experts.
ARVD/Cardiomyopathy: Interview with Expert Hugh Calkins, MD
While ARVD/C management has greatly improved, more precautions—particularly in genetic testing and exercise—need to be taken.
Clinician Viewpoints on the "2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure"
Drs Tauras and Patel from Montefiore Medical Center in the Bronx, New York weigh in on what the new heart failure therapeutic guidelines mean for practicing clinicians.
Managing Cardiovascular Complications of Oncology Treatment
Clinicians seek stronger collaboration between cardiology and oncology as well as evidence-based treatment guidelines.
Ixmyelocel-T Cell-Based Therapy Reduced Cardiac Events in Heart Failure
Ixmyelocel-T therapy reduced clinical cardiac events and improved patient outcomes.
Better Late Than Never: Exercise as Primary and Secondary Prevention in CVD
Exercise's potential positive effects on cardiovascular disease and heart failure may be possible regardless of frequency and time of initiation.
Latest News
Heart Meds Recalled After Discovery of Possible Carcinogenic Impurity
As valsartan is used to treat various cardiovascular conditions including heart failure and hypertension, patients should continue to take their medications until they have a replacement product,
Heart Failure Risk Increased When Sleep Apnea Not Managed With CPAP
When sleep apnea was not managed with continuous positive airway pressure, the risk for heart failure increased, regardless of age.
Intensified, Multifactorial Intervention for Type 2 Diabetes Reduces Risk for Heart Failure
Investigators examined the effect of intensified multifactorial intervention on the risk for heart failure-related hospitalization in patients with type 2 diabetes and microalbuminuria.
Clinical Significance of Genetic Variations in CYP2D6 Investigated in HF Patients
According to HF guidelines, beta-blockers must be titrated to a specific target dose in order to obtain their morbidity and mortality benefit in HF patients.
SGLT2 Inhibitor Use Linked to Lower Risk for Heart Failure, Death in Type 2 Diabetes
Regardless of presence of preexisting cardiovascular disease, SGLT2 inhibitors were associated with lower risk for death and heart failure.
LV Strain, Hypertrophy Predict Heart Failure in Asymptomatic T2D
Impaired global longitudinal strain and left ventricular hypertrophy may be predictive of incident heart failure in patients with asymptomatic type 2 diabetes.
Acute Myocarditis Complicated by LVSD Has Different Presentation, Outcomes
Acute myocarditis complicated by left ventricular systolic dysfunction confers a higher risk for cardiac death and heart transplant compared with uncomplicated acute myocarditis.
Neprilysin Inhibition May Reduce Renal Function Deterioration in Comorbid T2D and Chronic Heart Failure
This study aimed to examine the efficacy of neprilysin inhibition in treating renal disease in individuals with T2D.
FDA Recall: HeartMate 3™ Outflow Graft Assembly Malfunction
The HeartMate 3™ Left Ventricular Assist System has been recalled because of a potential malfunction in the outflow graft assembly that may cause it to twist and close up over time.
Single-Beat Approach Estimates Preload Recruitable Stroke Work Relationship in PAH
A single-beat estimation of preload recruitable stroke work and its coupling with pulmonary arterial load in pulmonary arterial hypertension provided high accuracy for evaluating right ventricular contractility.
The Cardiology Advisor Articles
- Heart Failure Risk Increased When Sleep Apnea Not Managed With CPAP
- USPSTF: Evidence Lacking for ABI for PAD Screening in Asymptomatic Adults
- α-Gal Sensitization and Coronary Artery Disease: What's the Link?
- Apixaban Is Safest Direct Oral Anticoagulant vs Warfarin
- Heart Meds Recalled After Discovery of Possible Carcinogenic Impurity
- Heart Failure Risk Increased When Sleep Apnea Not Managed With CPAP
- Pulmonary Embolism AEs Increase With DOAC Doses Against Manufacturer Recs
- Permanent Pacemaker After TAVR Increases Mortality, Readmission Risks
- USPSTF: Evidence Lacking for ABI for PAD Screening in Asymptomatic Adults
- Apixaban Is Safest Direct Oral Anticoagulant vs Warfarin
- FDA Outlines Plan for Increasing Nonprescription Drug Availability
- Erenumab May Help Prevent Migraines in Patients With Heart Disease
- Gender Bias in Medicine Has Far-Reaching Consequences
- Preeclampsia, Gestational Hypertension Increases CVD Risk Later in Life
- α-Gal Sensitization and Coronary Artery Disease: What's the Link?